Related Experiment Videos
[Immunoglobulin substitution in malignant lymphoma]
1Medizinische Klinik und Poliklinik, Heinrich-Heine-Universität, Düsseldorf.
Infusionstherapie Und Transfusionsmedizin
|April 1, 1993
Summary
Intravenous immunoglobulin therapy may reduce bacterial infections in lymphoma patients with chronic lymphocytic leukemia and multiple myeloma. However, it did not decrease deaths from infections, and its benefit for quality of life remains unclear.
Area of Science:
- Hematology
- Immunology